Senti Biosciences issues senior secured convertible notes with 200% maturity payment.
Senti Holdings Inc. issued senior secured convertible notes requiring 200% repayment of principal at maturity. The offering provides capital financing with conversion rights, typical for biotech companies seeking non-dilutive funding.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day